Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Jul 1;26(13):3492.
doi: 10.1158/1078-0432.CCR-20-1073.

Plasma Tumor Mutation Burden and Response to Pembrolizumab-Response

Charu Aggarwal  1 , Jeffrey C Thompson  2 , Erica L Carpenter  2
Affiliations
Comment

Plasma Tumor Mutation Burden and Response to Pembrolizumab-Response

Charu Aggarwal et al. Clin Cancer Res. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Skoulidis F, et al. , STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma. Cancer Discov, 2018. 8(7): p. 822–835. - PMC - PubMed
    1. Rizvi NA, et al. LBA6Durvalumab with or without tremelimumab vs platinum-based chemotherapy as first-line treatment for metastatic non-small cell lung cancer: MYSTIC. in ESMO Immuno-Oncology Congress. 2018. Geneva, Switzerland: EMSO.
    1. Kim ES, et al. , LBA55Primary efficacy results from B-F1RST, a prospective phase II trial evaluating blood-based tumour mutational burden (bTMB) as a predictive biomarker for atezolizumab (atezo) in 1L non-small cell lung cancer (NSCLC). Annals of Oncology, 2018. 29(suppl_8).

Substances